Castle Biosciences

Recent Finacing

Convertible

Recent Raise

$12M

Castle Biosciences develops DecisionDx gene-expression diagnostics to assess metastatic risk and guide treatment for cutaneous and uveal melanoma; headquartered in Friendswood, Texas, with laboratories in Phoenix, Arizona.

Founded 2008

Texas, United States

501-1K

Publicly Traded

castlebiosciences.com

Highlights

Focus Areas

Biotechnology

Health Care

Health Diagnostics

Recent Investors

L

Financials

$55.5M

Total Raised

5

Funding rounds

6

Investors

Team

Upgrade to view the team

See the team members at Castle Biosciences.